A program to improve diabetes management for Latinx patients using technology and behavioral economics
DM-BOOST Para Latinx: a Diabetes Mellitus Program Using Behavioral Economics to Optimize Outreach and Self-management Support With Technology for Latinx Patients
This study is testing a new program that uses technology and behavioral strategies to help Latinx patients with type 2 diabetes manage their condition better.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Massachusetts, Worcester Academic / other |
| Locations | 2 sites (Worcester, Massachusetts and 1 other locations) |
| Trial ID | NCT05583877 on ClinicalTrials.gov |
What this trial studies
This project aims to culturally adapt the DM-BOOST intervention specifically for Latinx patients with type 2 diabetes. It will involve usability testing to ensure the program is culturally appropriate and engaging for participants. The study will utilize a community-based participatory research approach, collaborating with clinical, community, and patient partners to enhance outreach and self-management support. The findings will inform future proposals for implementing the DM-BOOST program within the UMass Memorial Health Care system.
Who should consider this trial
Good fit: Ideal candidates for this study are Hispanic/Latinx individuals over 18 years old who have been diagnosed with type 2 diabetes and prefer to communicate in Spanish.
Not a fit: Patients with cognitive impairments, current prisoners, pregnant women, or those who have completed diabetes self-management training in the past year may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve diabetes management and health outcomes for Latinx patients.
How similar studies have performed: Other studies have shown success in using culturally tailored interventions for diabetes management, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Aims 1 and 2 Patient Inclusion Criteria: * Age \> 18 years * Diagnosis of type 2 diabetes * Identifies as Hispanic/Latinx * Spanish language preference Aims 1 and 2 Patient Exclusion Criteria: * Cognitive impairment * Current prisoner * Pregnant women Aim 3 Patient Inclusion Criteria: * Age \> 18 years * Diagnosis of type 2 diabetes * Identifies as Hispanic/Latinx * Spanish language preference Aim 3 Patient Exclusion Criteria: * Cognitive impairment * Current prisoner * Pregnant women * Completed DSMT in previous year
Where this trial is running
Worcester, Massachusetts and 1 other locations
- UMass Memorial health — Worcester, Massachusetts, United States (Recruiting)
- University of Massachusetts Medical School — Worcester, Massachusetts, United States (Not_yet_recruiting)
Study contacts
- Principal investigator: Daniel J Amante, PhD, MPH — UMass Chan Medical School
- Study coordinator: Daniel J Amante, PhD, MPH
- Email: daniel.amante@umassmed.edu
- Phone: 508-856-8480
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.